KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Total Current Liabilities (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Total Current Liabilities for 8 consecutive years, with $89.9 million as the latest value for Q4 2025.

  • Quarterly Total Current Liabilities fell 8.3% to $89.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $89.9 million through Dec 2025, down 8.3% year-over-year, with the annual reading at $89.9 million for FY2025, 8.3% down from the prior year.
  • Total Current Liabilities hit $89.9 million in Q4 2025 for Adaptive Biotechnologies, up from $83.4 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $122.4 million in Q3 2021 to a low of $83.0 million in Q1 2024.
  • Historically, Total Current Liabilities has averaged $98.8 million across 5 years, with a median of $94.3 million in 2023.
  • Biggest five-year swings in Total Current Liabilities: soared 36.97% in 2021 and later dropped 21.7% in 2023.
  • Year by year, Total Current Liabilities stood at $113.8 million in 2021, then fell by 3.53% to $109.8 million in 2022, then fell by 19.83% to $88.0 million in 2023, then increased by 11.4% to $98.1 million in 2024, then decreased by 8.3% to $89.9 million in 2025.
  • Business Quant data shows Total Current Liabilities for ADPT at $89.9 million in Q4 2025, $83.4 million in Q3 2025, and $92.1 million in Q2 2025.